{"id":"W2978854127","doi":"10.1093/annonc/mdz394.008","title":"Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Veliparib; Medicine; Carboplatin; Paclitaxel; Oncology; Metastatic breast cancer; PARP inhibitor; Internal medicine; Breast cancer; Cancer; Chemotherapy; Cisplatin; Poly ADP ribose polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007343348,0.0001663439,0.0009896578,0.0002295007,0.00001966446,0.000003327236,0.0001055154,0.00009142511,0.0002793348],"category_scores_gemma":[0.0002075114,0.0001336935,0.00003695916,0.0005234152,0.0002155095,0.00007841257,0.00006604751,0.0003393762,0.000003690426],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001521057,"about_ca_system_score_gemma":0.0007666585,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007346254,"about_ca_topic_score_gemma":0.007283806,"domain_scores_codex":[0.9980407,0.0003059394,0.0005252226,0.0003355086,0.0004099811,0.0003826778],"domain_scores_gemma":[0.9983302,0.0004004532,0.0003351264,0.0002684639,0.0005280813,0.0001376712],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02262781,0.02387866,0.7036175,0.0008428525,0.001667073,0.0004542642,0.02419885,0.0003623374,0.01184316,0.00006810403,0.001605076,0.2088343],"study_design_scores_gemma":[0.1023247,0.07828344,0.7912093,0.001161885,0.0002335392,0.00006678799,0.02027448,0.0005826876,0.004515401,0.0002251563,0.0007619358,0.000360723],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944241,0.0004139532,0.000001405899,0.001575879,0.00005544423,0.001491462,0.000119063,0.000009917645,0.001908779],"genre_scores_gemma":[0.9988461,0.0002996158,0.0001237596,0.0002576977,0.00001782721,0.0001281084,0.000007605061,0.00002511371,0.0002941851],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2084735,"threshold_uncertainty_score":0.9992639,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09477682576886066,"score_gpt":0.4793402547310751,"score_spread":0.3845634289622144,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}